References list

• Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
  De Filette, Marina, et al. PLoS ONE 2014;9: e87837
• Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.
  Koopman, Gerrit, et al. J. Gen. Virol. 2008 Feb;89: 540-53
• A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
  Martina, Byron E E, et al. PLoS ONE 2011 Apr 26;6: e18995
• Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
  Pichyangkul, Sathit, et al. Vaccine 2004 Sep 28;22: 3831-40
• Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.
  Walsh, Douglas S, et al. Am. J. Trop. Med. Hyg. 2004 May;70: 499-509
• Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor.
  Wilkie, Scott, et al. J. Immunol. 2008 Apr 01;180: 4901-9